Recent research has expanded into the realm of epigenetics, focusing on how changes in gene activity that don't involve alterations to the underlying DNA sequence can drive breast cancer. Therapies targeting these epigenetic modifications, such as DNA methylation and histone modification, offer a new avenue for treatment, potentially reversing aberrant gene expression profiles that contribute to cancer progression and resistance to conventional therapies.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.